Status:
UNKNOWN
COVID19 Clinical Predictors and Outcome
Lead Sponsor:
St George's University Hospitals NHS Foundation Trust
Conditions:
COVID
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
In December 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, Hubei, China, and now spreads across international borders. As of 11 April 2020, the total global number of confirmed SARS-CoV-2 ca...
Detailed Description
The majority of published reports on early clinical descriptions of COVID-19 have emerged from Hubei province in China, and although these provide valuable information, the lack of standardised mortal...
Eligibility Criteria
Inclusion
- Workstream 1
- Adults (aged ≥18 years).
- Patients attending SGHFT.
Exclusion
- Children and adolescents (\< 18 years). Workstream 2
- Inclusion Criteria:
- Adult (aged ≥18 years) patients admitted to ICU areas during the period of study
- Presence of acute respiratory failure: this is defined by meeting all the following criteria:
- Onset over 1 week or less
- Presence of consolidation, or bilateral opacities on CT or chest radiograph.
- PaO2 \< 8 kPa on FiO2 0.21 or requirement of non-invasive ventilation (NIV), high-flow nasal cannula (HFNC) or mechanical ventilation
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04416347
Start Date
June 15 2020
End Date
April 30 2022
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. George's University Hospitals Foundation Trust.
London, United Kingdom, SW17 0RE